It is believed that prevailing a blockade induced by Bcl2 or Bcl-xl could restore normal cellular homeostasis, reverse the drug-resistant phenotype, and restore tumor cell sensitivity to conventional chemotherapeutics [5, 20, 21]. This evidence concerns the gene BCL2L1 and neoplasm.